Fangchinoline protects hepatic ischemia/reperfusion liver injury in rats through anti‐oxidative stress and anti‐inflammation properties: an in silico study

Liver ischemia‐reperfusion (I/R) injury is a common cause of organ failure, developed by a sudden block in the blood and oxygen supply and subsequent restoration. I/R damage is responsible for acute and chronic rejection after organ transplantation, accounting for 10% of early graft failure. The stu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biotechnology and applied biochemistry 2024-12, Vol.71 (6), p.1281-1292
Hauptverfasser: Li, Shuangxi, Xiang, AnDong, Guo, Feng, Alarfaj, Abdullah A., Gao, Zehai
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1292
container_issue 6
container_start_page 1281
container_title Biotechnology and applied biochemistry
container_volume 71
creator Li, Shuangxi
Xiang, AnDong
Guo, Feng
Alarfaj, Abdullah A.
Gao, Zehai
description Liver ischemia‐reperfusion (I/R) injury is a common cause of organ failure, developed by a sudden block in the blood and oxygen supply and subsequent restoration. I/R damage is responsible for acute and chronic rejection after organ transplantation, accounting for 10% of early graft failure. The study investigated the therapeutic properties of fangchinoline in liver injury‐induced rats. The rats were divided into three groups: Sham, I/R without pretreatment, and I/R + 10 mg/kg fangchinoline pretreatment. Blood and liver samples were collected for assays, and an in silico docking analysis was conducted to determine fangchinoline's inhibitory effect. The pretreatment with 10 mg/kg of fangchinoline effectively reduced hepatic marker enzymes such as AST, LDH, and ALT in the serum of rats with liver I/R damage. Fangchinoline treatment significantly reduced interleukin‐8 (IL‐8), IL‐6, and tumor necrosis factor‐α (TNF‐α) in I/R‐induced rats, boosting antioxidants and decreasing MDA. Histopathological studies showed liver injury protection, and fangchinoline inhibited TNF‐α and IL‐6 with improved binding affinity. Fangchinoline has hepatoprotective properties by reducing inflammation in rats with liver I/R damage, as demonstrated in the current study. Hence, it can be an effective salutary agent in preventing liver damage caused by I/R.
doi_str_mv 10.1002/bab.2628
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3077994906</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3141964702</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3108-17ae7b8702ed62f19d21d9202d289883cd86a8da054213e37e509f4b9be520653</originalsourceid><addsrcrecordid>eNp1kU9u1TAQhy0Eoo-CxAlQJDZs0vpfYptdW1FAqsQG1pYTTxo_JfbDTgpvxxG4AXfjJMyjLUhIrEbyfPN5Rj9CnjN6wijlp53rTnjL9QOyYVLRWispH5IN1bqpZcPEEXlSypZSqpXmj8mR0EbLlqoN-XHp4nU_hpimEKHa5bRAv5RqhJ1bQl-F0o8wB3eaYQd5WEtIsZrCDeQqxO2a91iq7HBiGXNar8fKxSX8_PY9fQ0eDTdQlSVDKfju73shDpObZ2yjDL9E8xKgvMb-QVfCFPqEc6vfPyWPBjcVeHZXj8mnyzcfL97VVx_evr84u6p7waiumXKgOq0oB9_ygRnPmTeccs_xVC16r1unvaON5EyAUNBQM8jOdNBw2jbimLy69eI6n1coi53xdJgmFyGtxQqqlDHS0BbRl_-g27TmiNtZwSQzLSbA_wr7nErJMNhdDrPLe8uoPYRmMTR7CA3RF3fCtZvB_wHvU0KgvgW-hAn2_xXZ87Pz38Jf3hGlBg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3141964702</pqid></control><display><type>article</type><title>Fangchinoline protects hepatic ischemia/reperfusion liver injury in rats through anti‐oxidative stress and anti‐inflammation properties: an in silico study</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Li, Shuangxi ; Xiang, AnDong ; Guo, Feng ; Alarfaj, Abdullah A. ; Gao, Zehai</creator><creatorcontrib>Li, Shuangxi ; Xiang, AnDong ; Guo, Feng ; Alarfaj, Abdullah A. ; Gao, Zehai</creatorcontrib><description>Liver ischemia‐reperfusion (I/R) injury is a common cause of organ failure, developed by a sudden block in the blood and oxygen supply and subsequent restoration. I/R damage is responsible for acute and chronic rejection after organ transplantation, accounting for 10% of early graft failure. The study investigated the therapeutic properties of fangchinoline in liver injury‐induced rats. The rats were divided into three groups: Sham, I/R without pretreatment, and I/R + 10 mg/kg fangchinoline pretreatment. Blood and liver samples were collected for assays, and an in silico docking analysis was conducted to determine fangchinoline's inhibitory effect. The pretreatment with 10 mg/kg of fangchinoline effectively reduced hepatic marker enzymes such as AST, LDH, and ALT in the serum of rats with liver I/R damage. Fangchinoline treatment significantly reduced interleukin‐8 (IL‐8), IL‐6, and tumor necrosis factor‐α (TNF‐α) in I/R‐induced rats, boosting antioxidants and decreasing MDA. Histopathological studies showed liver injury protection, and fangchinoline inhibited TNF‐α and IL‐6 with improved binding affinity. Fangchinoline has hepatoprotective properties by reducing inflammation in rats with liver I/R damage, as demonstrated in the current study. Hence, it can be an effective salutary agent in preventing liver damage caused by I/R.</description><identifier>ISSN: 0885-4513</identifier><identifier>ISSN: 1470-8744</identifier><identifier>EISSN: 1470-8744</identifier><identifier>DOI: 10.1002/bab.2628</identifier><identifier>PMID: 38984607</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Animals ; Anti-Inflammatory Agents - chemistry ; Anti-Inflammatory Agents - pharmacology ; Antioxidants - chemistry ; Antioxidants - metabolism ; Antioxidants - pharmacology ; Benzylisoquinolines - chemistry ; Benzylisoquinolines - pharmacology ; Blood ; Computer Simulation ; Damage prevention ; Enzyme inhibitors ; fangchinoline ; Graft rejection ; hepatoprotection ; Inflammation ; Injury prevention ; Interleukin 6 ; Ischemia ; ischemia/reperfusion ; Liver ; Liver - drug effects ; Liver - metabolism ; Liver - pathology ; liver injury ; Liver transplantation ; Male ; Molecular Docking Simulation ; Oxidative stress ; Oxidative Stress - drug effects ; Pretreatment ; Rats ; Rats, Wistar ; Reperfusion ; Reperfusion Injury - drug therapy ; Reperfusion Injury - metabolism ; Reperfusion Injury - pathology ; Reperfusion Injury - prevention &amp; control ; Tumor necrosis factor ; Tumor necrosis factor-TNF ; Xenografts</subject><ispartof>Biotechnology and applied biochemistry, 2024-12, Vol.71 (6), p.1281-1292</ispartof><rights>2024 International Union of Biochemistry and Molecular Biology, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3108-17ae7b8702ed62f19d21d9202d289883cd86a8da054213e37e509f4b9be520653</cites><orcidid>0009-0006-2937-6644</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fbab.2628$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fbab.2628$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38984607$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Shuangxi</creatorcontrib><creatorcontrib>Xiang, AnDong</creatorcontrib><creatorcontrib>Guo, Feng</creatorcontrib><creatorcontrib>Alarfaj, Abdullah A.</creatorcontrib><creatorcontrib>Gao, Zehai</creatorcontrib><title>Fangchinoline protects hepatic ischemia/reperfusion liver injury in rats through anti‐oxidative stress and anti‐inflammation properties: an in silico study</title><title>Biotechnology and applied biochemistry</title><addtitle>Biotechnol Appl Biochem</addtitle><description>Liver ischemia‐reperfusion (I/R) injury is a common cause of organ failure, developed by a sudden block in the blood and oxygen supply and subsequent restoration. I/R damage is responsible for acute and chronic rejection after organ transplantation, accounting for 10% of early graft failure. The study investigated the therapeutic properties of fangchinoline in liver injury‐induced rats. The rats were divided into three groups: Sham, I/R without pretreatment, and I/R + 10 mg/kg fangchinoline pretreatment. Blood and liver samples were collected for assays, and an in silico docking analysis was conducted to determine fangchinoline's inhibitory effect. The pretreatment with 10 mg/kg of fangchinoline effectively reduced hepatic marker enzymes such as AST, LDH, and ALT in the serum of rats with liver I/R damage. Fangchinoline treatment significantly reduced interleukin‐8 (IL‐8), IL‐6, and tumor necrosis factor‐α (TNF‐α) in I/R‐induced rats, boosting antioxidants and decreasing MDA. Histopathological studies showed liver injury protection, and fangchinoline inhibited TNF‐α and IL‐6 with improved binding affinity. Fangchinoline has hepatoprotective properties by reducing inflammation in rats with liver I/R damage, as demonstrated in the current study. Hence, it can be an effective salutary agent in preventing liver damage caused by I/R.</description><subject>Animals</subject><subject>Anti-Inflammatory Agents - chemistry</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Antioxidants - chemistry</subject><subject>Antioxidants - metabolism</subject><subject>Antioxidants - pharmacology</subject><subject>Benzylisoquinolines - chemistry</subject><subject>Benzylisoquinolines - pharmacology</subject><subject>Blood</subject><subject>Computer Simulation</subject><subject>Damage prevention</subject><subject>Enzyme inhibitors</subject><subject>fangchinoline</subject><subject>Graft rejection</subject><subject>hepatoprotection</subject><subject>Inflammation</subject><subject>Injury prevention</subject><subject>Interleukin 6</subject><subject>Ischemia</subject><subject>ischemia/reperfusion</subject><subject>Liver</subject><subject>Liver - drug effects</subject><subject>Liver - metabolism</subject><subject>Liver - pathology</subject><subject>liver injury</subject><subject>Liver transplantation</subject><subject>Male</subject><subject>Molecular Docking Simulation</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Pretreatment</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Reperfusion</subject><subject>Reperfusion Injury - drug therapy</subject><subject>Reperfusion Injury - metabolism</subject><subject>Reperfusion Injury - pathology</subject><subject>Reperfusion Injury - prevention &amp; control</subject><subject>Tumor necrosis factor</subject><subject>Tumor necrosis factor-TNF</subject><subject>Xenografts</subject><issn>0885-4513</issn><issn>1470-8744</issn><issn>1470-8744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kU9u1TAQhy0Eoo-CxAlQJDZs0vpfYptdW1FAqsQG1pYTTxo_JfbDTgpvxxG4AXfjJMyjLUhIrEbyfPN5Rj9CnjN6wijlp53rTnjL9QOyYVLRWispH5IN1bqpZcPEEXlSypZSqpXmj8mR0EbLlqoN-XHp4nU_hpimEKHa5bRAv5RqhJ1bQl-F0o8wB3eaYQd5WEtIsZrCDeQqxO2a91iq7HBiGXNar8fKxSX8_PY9fQ0eDTdQlSVDKfju73shDpObZ2yjDL9E8xKgvMb-QVfCFPqEc6vfPyWPBjcVeHZXj8mnyzcfL97VVx_evr84u6p7waiumXKgOq0oB9_ygRnPmTeccs_xVC16r1unvaON5EyAUNBQM8jOdNBw2jbimLy69eI6n1coi53xdJgmFyGtxQqqlDHS0BbRl_-g27TmiNtZwSQzLSbA_wr7nErJMNhdDrPLe8uoPYRmMTR7CA3RF3fCtZvB_wHvU0KgvgW-hAn2_xXZ87Pz38Jf3hGlBg</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Li, Shuangxi</creator><creator>Xiang, AnDong</creator><creator>Guo, Feng</creator><creator>Alarfaj, Abdullah A.</creator><creator>Gao, Zehai</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TB</scope><scope>7TK</scope><scope>7U5</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>L7M</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0009-0006-2937-6644</orcidid></search><sort><creationdate>202412</creationdate><title>Fangchinoline protects hepatic ischemia/reperfusion liver injury in rats through anti‐oxidative stress and anti‐inflammation properties: an in silico study</title><author>Li, Shuangxi ; Xiang, AnDong ; Guo, Feng ; Alarfaj, Abdullah A. ; Gao, Zehai</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3108-17ae7b8702ed62f19d21d9202d289883cd86a8da054213e37e509f4b9be520653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>Anti-Inflammatory Agents - chemistry</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Antioxidants - chemistry</topic><topic>Antioxidants - metabolism</topic><topic>Antioxidants - pharmacology</topic><topic>Benzylisoquinolines - chemistry</topic><topic>Benzylisoquinolines - pharmacology</topic><topic>Blood</topic><topic>Computer Simulation</topic><topic>Damage prevention</topic><topic>Enzyme inhibitors</topic><topic>fangchinoline</topic><topic>Graft rejection</topic><topic>hepatoprotection</topic><topic>Inflammation</topic><topic>Injury prevention</topic><topic>Interleukin 6</topic><topic>Ischemia</topic><topic>ischemia/reperfusion</topic><topic>Liver</topic><topic>Liver - drug effects</topic><topic>Liver - metabolism</topic><topic>Liver - pathology</topic><topic>liver injury</topic><topic>Liver transplantation</topic><topic>Male</topic><topic>Molecular Docking Simulation</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Pretreatment</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Reperfusion</topic><topic>Reperfusion Injury - drug therapy</topic><topic>Reperfusion Injury - metabolism</topic><topic>Reperfusion Injury - pathology</topic><topic>Reperfusion Injury - prevention &amp; control</topic><topic>Tumor necrosis factor</topic><topic>Tumor necrosis factor-TNF</topic><topic>Xenografts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Shuangxi</creatorcontrib><creatorcontrib>Xiang, AnDong</creatorcontrib><creatorcontrib>Guo, Feng</creatorcontrib><creatorcontrib>Alarfaj, Abdullah A.</creatorcontrib><creatorcontrib>Gao, Zehai</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Mechanical &amp; Transportation Engineering Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biotechnology and applied biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Shuangxi</au><au>Xiang, AnDong</au><au>Guo, Feng</au><au>Alarfaj, Abdullah A.</au><au>Gao, Zehai</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fangchinoline protects hepatic ischemia/reperfusion liver injury in rats through anti‐oxidative stress and anti‐inflammation properties: an in silico study</atitle><jtitle>Biotechnology and applied biochemistry</jtitle><addtitle>Biotechnol Appl Biochem</addtitle><date>2024-12</date><risdate>2024</risdate><volume>71</volume><issue>6</issue><spage>1281</spage><epage>1292</epage><pages>1281-1292</pages><issn>0885-4513</issn><issn>1470-8744</issn><eissn>1470-8744</eissn><abstract>Liver ischemia‐reperfusion (I/R) injury is a common cause of organ failure, developed by a sudden block in the blood and oxygen supply and subsequent restoration. I/R damage is responsible for acute and chronic rejection after organ transplantation, accounting for 10% of early graft failure. The study investigated the therapeutic properties of fangchinoline in liver injury‐induced rats. The rats were divided into three groups: Sham, I/R without pretreatment, and I/R + 10 mg/kg fangchinoline pretreatment. Blood and liver samples were collected for assays, and an in silico docking analysis was conducted to determine fangchinoline's inhibitory effect. The pretreatment with 10 mg/kg of fangchinoline effectively reduced hepatic marker enzymes such as AST, LDH, and ALT in the serum of rats with liver I/R damage. Fangchinoline treatment significantly reduced interleukin‐8 (IL‐8), IL‐6, and tumor necrosis factor‐α (TNF‐α) in I/R‐induced rats, boosting antioxidants and decreasing MDA. Histopathological studies showed liver injury protection, and fangchinoline inhibited TNF‐α and IL‐6 with improved binding affinity. Fangchinoline has hepatoprotective properties by reducing inflammation in rats with liver I/R damage, as demonstrated in the current study. Hence, it can be an effective salutary agent in preventing liver damage caused by I/R.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>38984607</pmid><doi>10.1002/bab.2628</doi><tpages>12</tpages><orcidid>https://orcid.org/0009-0006-2937-6644</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0885-4513
ispartof Biotechnology and applied biochemistry, 2024-12, Vol.71 (6), p.1281-1292
issn 0885-4513
1470-8744
1470-8744
language eng
recordid cdi_proquest_miscellaneous_3077994906
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Animals
Anti-Inflammatory Agents - chemistry
Anti-Inflammatory Agents - pharmacology
Antioxidants - chemistry
Antioxidants - metabolism
Antioxidants - pharmacology
Benzylisoquinolines - chemistry
Benzylisoquinolines - pharmacology
Blood
Computer Simulation
Damage prevention
Enzyme inhibitors
fangchinoline
Graft rejection
hepatoprotection
Inflammation
Injury prevention
Interleukin 6
Ischemia
ischemia/reperfusion
Liver
Liver - drug effects
Liver - metabolism
Liver - pathology
liver injury
Liver transplantation
Male
Molecular Docking Simulation
Oxidative stress
Oxidative Stress - drug effects
Pretreatment
Rats
Rats, Wistar
Reperfusion
Reperfusion Injury - drug therapy
Reperfusion Injury - metabolism
Reperfusion Injury - pathology
Reperfusion Injury - prevention & control
Tumor necrosis factor
Tumor necrosis factor-TNF
Xenografts
title Fangchinoline protects hepatic ischemia/reperfusion liver injury in rats through anti‐oxidative stress and anti‐inflammation properties: an in silico study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T03%3A19%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fangchinoline%20protects%20hepatic%20ischemia/reperfusion%20liver%20injury%20in%20rats%20through%20anti%E2%80%90oxidative%20stress%20and%20anti%E2%80%90inflammation%20properties:%20an%20in%20silico%20study&rft.jtitle=Biotechnology%20and%20applied%20biochemistry&rft.au=Li,%20Shuangxi&rft.date=2024-12&rft.volume=71&rft.issue=6&rft.spage=1281&rft.epage=1292&rft.pages=1281-1292&rft.issn=0885-4513&rft.eissn=1470-8744&rft_id=info:doi/10.1002/bab.2628&rft_dat=%3Cproquest_cross%3E3141964702%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3141964702&rft_id=info:pmid/38984607&rfr_iscdi=true